Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $340.38 | $19.28 | 1,665.07% | 6,807.60x | 100.48x | 7.54x | 9.13x | 6.57x | $529.27M | 1.41% | $4.13B | 37.48 | $35.57B | 111.85 | ||
| NVO | NOVO NORDISK A S | $59.43 | $148.32 | -59.93% | 16.53x | 2.61x | 5.43x | 10.09x | 0.17x | $9.34B | 3.54% | $26.18B | 5.89 | $274.73B | 11.07 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $338.06 | $36.93 | 815.32% | 1,090.52x | 47.20x | 13.84x | 190.95x | 3.53x | $221.36M | 0.50% | $233.89M | 1.78 | $46.39B | 305.32 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $43.92 | $17.25 | 154.55% | 89.63x | 25.71x | 5.49x | 6.22x | 1.12x | $101.73M | 3.10% | $535.38M | 7.17 | $3.16B | 59.05 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.00 | $16.44 | -45.24% | 18.75x | 15.83x | 5.97x | 3.80x | 0.24x | -$23.64M | -4.70% | $133.17M | 2.38 | $514.96M | 7.66 | ||
| CORT | CORCEPT THERAPEUTICS INC | $39.87 | $41.49 | -3.92% | 39.87x | 79.45x | 5.57x | 6.64x | 0.41x | $162.57M | 3.94% | $631.90M | 6.10 | $4.08B | 61.77 | ||
| VCEL | VERICEL CORP | $35.98 | $9.55 | 276.85% | 138.38x | 61.89x | 7.02x | 5.65x | 1.64x | $20.38M | 1.12% | $321.86M | 6.38 | $1.82B | 62.00 | ||
| ARGX | ARGENX SE | $840.50 | $370.29 | 126.99% | 33.59x | 28.03x | 27,112.90x | 7.15x | 1.36x | $467.72M | 0.91% | $7.17B | 117.50 | $48.90B | 60.27 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.09 | $19.12 | -73.38% | 3.20x | -94.43x | 727.14x | 1.61x | 0.19x | -$82.36M | -29.82% | $171.23M | 3.16 | $216.72M | 2.41 | ||
| TECH | BIO-TECHNE CORP | $64.09 | $16.23 | 294.81% | 128.18x | 31.73x | 8.19x | 5.08x | 1.76x | $224.06M | 2.25% | $1.97B | 12.65 | $10.24B | 46.34 | ||
| ADMA | ADMA BIOLOGICS INC | $17.30 | $12.74 | 35.75% | 19.66x | 18.95x | 8.45x | 9.55x | 0.83x | $40.73M | 0.99% | $431.19M | 1.81 | $4.13B | 23.99 | ||
| GMAB | GENMAB A | $32.63 | $127.92 | -74.49% | 13.93x | 1.93x | 5.88x | 3.64x | 0.10x | $1.19B | 5.70% | $5.75B | 8.96 | $19.33B | 9.66 | ||
| KRYS | KRYSTAL BIOTECH INC | $279.24 | $115.83 | 141.08% | 40.47x | 34.46x | 21.66x | 7.12x | 1.35x | $166.02M | 2.05% | $1.14B | 39.30 | $7.71B | 39.91 | ||
| MNKD | MANNKIND CORP | $5.78 | $2.92 | 97.84% | 57.80x | 47.22x | 5.65x | -39.84x | 0.90x | $43.39M | 2.44% | -$44.55M | -0.15 | $2.01B | 27.43 | ||
| VCYT | VERACYTE INC | $38.08 | $12.64 | 201.25% | 97.64x | 35.59x | 6.06x | 2.39x | 1.34x | $98.21M | 3.28% | $1.26B | 15.98 | $2.73B | 47.96 | ||
| RPRX | ROYALTY PHARMA PLC | $41.68 | $47.26 | -11.80% | 23.68x | 8.03x | 7.66x | 2.50x | 0.41x | $2.11B | 11.73% | $9.62B | 22.28 | $32.07B | 30.71 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $14.53 | $9.85 | 47.48% | 25.05x | 15.24x | 7.20x | 5.24x | 0.82x | $119.87M | 6.26% | $365.77M | 2.78 | $1.92B | 18.55 | ||
| XOMA | XOMA ROYALTY CORP | $25.66 | $15.86 | 61.84% | 31.68x | 81.62x | 6.61x | 3.61x | 0.84x | -$12.41M | -3.98% | $87.94M | 7.25 | $359.19M | 13.43 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $5.99 | $4.33 | 38.48% | 22.19x | 19.91x | 3.83x | 6.76x | 0.79x | $21.15M | 4.42% | $70.68M | 0.89 | $416.80M | 18.37 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $192.10 | $72.32 | 165.61% | 83.16x | 22.71x | 14.97x | 3.98x | 1.19x | $30.76M | 0.82% | $950.17M | 48.53 | $4.09B | 39.73 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $22.58 | $6.50 | 247.35% | 64.51x | -19.92x | 2.81x | 7.12x | 1.85x | $78.64M | 2.75% | $401.17M | 3.17 | $2.85B | 30.54 | ||
| EXEL | EXELIXIS INC | $41.36 | $36.54 | 13.20% | 16.81x | 12.75x | 4.85x | 5.13x | 0.68x | $779.77M | 7.02% | $2.16B | 8.05 | $10.89B | 11.74 | ||
| HALO | HALOZYME THERAPEUTICS INC | $71.71 | $81.03 | -11.50% | 14.66x | 8.58x | 6.76x | 16.73x | 0.50x | $602.40M | 7.17% | $503.92M | 4.30 | $9.52B | 11.26 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.34 | $3.58 | -34.56% | 33.43x | 13.24x | 3.00x | 3.56x | 0.27x | -$11.69M | -6.28% | $52.91M | 0.67 | $182.72M | 20.60 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.30 | $23.44 | 3.66% | 13.58x | 13.20x | 5.15x | 3.25x | 0.68x | $234.54M | 7.87% | $920.25M | 7.51 | $2.30B | 7.10 | ||
| CRMD | CORMEDIX INC | $7.76 | $15.08 | -48.55% | 3.42x | 4.10x | 2.75x | 1.63x | 1.40x | $74.42M | 12.63% | $374.13M | 4.93 | $711.83M | 6.34 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $469.90 | $190.37 | 146.84% | 32.84x | 23.08x | 10.25x | 6.88x | 1.60x | $3.34B | 2.78% | $17.32B | 67.76 | $116.12B | 24.91 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $56.54 | $51.20 | 10.44% | 20.79x | 12.18x | 3.51x | 1.79x | 0.58x | $832.13M | 7.66% | $6.06B | 31.54 | $10.21B | 13.21 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.52 | $61.29 | -40.42% | 11.31x | 8.64x | 2.54x | 2.52x | 0.31x | $296.89M | 14.13% | $835.12M | 14.51 | $1.62B | 6.03 | ||
| UTHR | UNITED THERAPEUTICS CORP | $469.49 | $255.26 | 83.93% | 16.48x | 15.93x | 6.57x | 3.07x | 1.88x | $1.12B | 5.46% | $6.59B | 150.46 | $18.87B | 10.64 | ||
| MDXG | MIMEDX GROUP INC | $5.11 | $5.06 | 0.91% | 18.25x | 20.45x | 1.92x | 3.17x | 0.54x | $66.82M | 8.83% | $238.95M | 1.61 | $632.93M | 9.14 | ||
| INVA | INNOVIVA INC | $20.00 | $19.41 | 3.05% | 10.58x | 9.15x | 3.55x | 1.48x | 0.86x | $196.54M | 14.23% | $1.01B | 14.63 | $1.28B | 5.94 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $741.45 | $414.85 | 78.73% | 17.06x | 16.04x | 5.39x | 2.52x | 1.65x | $4.22B | 5.50% | $30.96B | 298.82 | $78.13B | 13.68 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $25.13 | $12.29 | 104.55% | 16.01x | 31.14x | 4.05x | 4.63x | 2.83x | $197.81M | 4.66% | $917.27M | 5.43 | $4.03B | 14.00 | ||
| INCY | INCYTE CORP | $100.07 | $76.63 | 30.59% | 16.57x | 12.45x | 4.07x | 4.22x | 0.88x | $1.20B | 6.11% | $4.65B | 23.77 | $17.22B | 10.24 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.